
Innogen grants Arcera exclusive rights to its long-acting GLP-1 receptor agonist across Africa, Eastern Europe, Latin America and the Middle East.
about 4 years ago
Labs and Computing Power: The Missing Link for a Revolution by 2030about 4 years ago
A Culture of Quality: The Catalyst to Accelerate Innovationabout 4 years ago
A Mission of the Heartabout 4 years ago
The New Reality for Industry Dealmaking May be Setting Inabout 4 years ago
Is ESG a ‘Protection Racket’ or Long-Term Value Contributor?about 4 years ago
Digital Biomarkers Could Reshape CNS Diagnosis, Treatmentabout 4 years ago
Long-Sought Reforms To EU Drug Rules Hit A Snag—What Now?about 4 years ago
Recaps, Live & In Personabout 4 years ago
FDA Keeps Its User Fees, but Fails to Gain Important Reforms




